glp-1 kidney news receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal. Read GLP-1 and the kidney: from

A caution on savings cards

Identification of the metabolites of the antioxidant flavonoid 7-mono-O-(-hydroxyethyl)-rutoside in mice

Powerful antioxidant Combats oxidative stress by neutralizing harmful free radicals, protecting cells from damage

Injections: A Comparison When deciding between lipotropic B12 oral supplements and injections, its essential to consider several key factors, such as absorption rates, bioavailability, and how your individual health needs might influence the effectiveness of each method

a life sentence for fake pill kingpin Aaron Shamo

To put this into raw numbers, 84 cases of ischemic optic neuropathy were reported in people taking semaglutide over the 7 years